BDBM50254758 (1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)pyridin-2-yl)-3-methylpiperazin-1-ylsulfonyl)methyl)-7,7-dimethylbicyclo[2.2.1]heptan-2-ol::CHEMBL464234

SMILES C[C@H]1CN(CCN1c1ncc(cc1F)C(F)(F)F)S(=O)(=O)C[C@]12CC[C@H](C[C@@H]1O)C2(C)C

InChI Key InChIKey=PMSFEOUVENKQAA-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50254758   

TargetC-X-C chemokine receptor type 3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 31.6nMAssay Description:Antagonist activity at human recombinant CXCR3 receptor expressed in CHO-K1 cells assessed as human IP10-induced calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 50.1nMAssay Description:Antagonist activity at human recombinant CXCR3 receptor expressed in CHO-K1 cells assessed as human IP10-induced calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 3(Mouse)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 158nMAssay Description:Antagonist activity at mouse recombinant CXCR3 expressed in human U2OS cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 3(Mouse)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 200nMAssay Description:Antagonist activity at mouse recombinant CXCR3 expressed in human U2OS cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibition of CYP3A4 greenMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of CYP3A4 redMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50254758((1S,2S,4R)-1-(((S)-4-(3-fluoro-5-(trifluoromethyl)...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed